May 9 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2025 Mar 31, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2 mln 122 mln
(-100.0 pct) (-52.5 pct)
Operating loss 419 mln loss 176 mln loss 1.34
Recurring loss 422 mln loss 127 mln loss 1.34
Net loss 429 mln loss 128 mln loss 1.35
EPS loss 9.04 yen loss 3.33 yen loss 28.43 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T